BDNF and Dravet syndrome: Therefore, we investigated the use of a possible pharmacological approach intended to promote BDNF signaling in patients with DS and provide evidence that the treatment of Ts65Dn mice with the BDNF-mimetic drug 7,8-dihydroxyflavone (DHF), completely rescued learning and memory impairments.